These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24089532)

  • 61. KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro.
    Hu J; Zhang LC; Song X; Lu JR; Jin Z
    Int J Clin Exp Pathol; 2015; 8(8):9182-8. PubMed ID: 26464664
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
    Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC
    Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma.
    Wright TM; Brannon AR; Gordan JD; Mikels AJ; Mitchell C; Chen S; Espinosa I; van de Rijn M; Pruthi R; Wallen E; Edwards L; Nusse R; Rathmell WK
    Oncogene; 2009 Jul; 28(27):2513-23. PubMed ID: 19448672
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Loss of Slfn3 induces a sex-dependent repair vulnerability after 50% bowel resection.
    Vomhof-DeKrey EE; Lansing JT; Darland DC; Umthun J; Stover AD; Brown C; Basson MD
    Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(2):G136-G152. PubMed ID: 33237796
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
    Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
    Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
    Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
    Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
    Sun S; Ning X; Liu J; Liu L; Chen Y; Han S; Zhang Y; Liang J; Wu K; Fan D
    Biochem Biophys Res Commun; 2007 May; 356(4):864-71. PubMed ID: 17400182
    [TBL] [Abstract][Full Text] [Related]  

  • 72. miR‑133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway.
    Xu Y; Ma Y; Liu XL; Gao SL
    Mol Med Rep; 2020 Jul; 22(1):67-76. PubMed ID: 32377748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
    Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
    Liu Y; Shang D
    Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression and functional role of miR-29b in renal cell carcinoma.
    Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
    Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation.
    Sohn WJ; Kim D; Lee KW; Kim MS; Kwon S; Lee Y; Kim DS; Kwon HJ
    Mol Immunol; 2007 Jul; 44(13):3273-82. PubMed ID: 17434208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Transcription Factor SAP30 Is Involved in the Activation of NETO2 Gene Expression in Clear Cell Renal Cell Carcinoma].
    Snezhkina AV; Nyushko KM; Zaretsky AR; Shagin DA; Sadritdinova AF; Fedorova MS; Guvatova ZG; Abramov IS; Pudova EA; Alekseev BY; Dmitriev AA; Kudryavtseva AV
    Mol Biol (Mosk); 2018; 52(3):451-459. PubMed ID: 29989576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.